Patients with severe eosinophilic asthma now have access to PBS reimbursed mepolizumab (Nucala) pre-filled pen autoinjector to allow self-administration of the biologic at home. From 1 June, a new PBS listing means that mepolizumab may be self-administered by autoinjector outside of clinic settings by the patient or administered by a caregiver if their healthcare professional ...
Mepolizumab pen autoinjector now available on PBS for severe eosinophilic asthma
By Michael Woodhead
9 Jun 2020